Come up with a name for your new list and we'll add to it:
Caerus Molecular Diagnostic raised a round of funding on August 04, 2014. Investors include
National Institutes of Health.
Caerus Molecular Diagnostic plans to test a technology that uses an engineered enzyme switch to convert the product of a single molecule DNA sequencing reaction into many copies of a reporter molecule…